AEM vs EGO

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

EGO presents a compelling value opportunity, trading at $32.07, which is below its Graham Number ($35.08) and significantly below its growth-based intrinsic value ($74.63). While the Piotroski F-Score of 4/9 indicates only stable financial health rather than strength, the company's low Debt/Equity (0.30) and strong liquidity (Current Ratio 1.83) provide a solid safety buffer. Explosive YoY earnings growth (134.8%) and a very low Forward P/E (5.48) suggest significant upside, though this is currently offset by a bearish technical trend and recent earnings misses.